Provided by Tiger Trade Technology Pte. Ltd.

Camp4 Therapeutics Corp.

4.34
+0.01000.23%
Volume:115.64K
Turnover:496.57K
Market Cap:272.35M
PE:-1.95
High:4.50
Open:4.30
Low:4.15
Close:4.33
52wk High:7.75
52wk Low:2.20
Shares:62.75M
Float Shares:38.46M
Volume Ratio:0.29
T/O Rate:0.30%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.2250
EPS(LYR):-2.6500
ROE:-545.85%
ROA:-45.25%
PB:-393.00
PE(LYR):-1.64

Loading ...

CAMP4 Therapeutics Corp Expected to Post a Loss of 21 Cents a Share - Earnings Preview

Reuters
·
Aug 10

Camp4 Therapeutics CEO Josh Mandel-Brehm Acquires 6,551 Common Shares for $10,809.15

Reuters
·
Aug 06

Camp4 Therapeutics Closes Second Tranche of Private Placement, Raises $50.1 Million

Reuters
·
Aug 04

Camp4 Therapeutics Announces Second Closing of $100 Million Private Placement

THOMSON REUTERS
·
Aug 04

CAMP4 Wins Australia Clearance to Start Phase 1/2 Trial of Cmp-002 in Syngap1 Disorder

Reuters
·
Jul 29

Analysts Offer Insights on NA Companies: CAMP4 Therapeutics Corporation (CAMP), Fiserv (FISV) and Rapport Therapeutics, Inc. (RAPP)

TIPRANKS
·
Jul 28

Camp4 Wins Australian Clearance for Phase 1/2 Cmp-002 Trial in SYNGAP1-related Disorder

Reuters
·
Jul 27

Camp4 Therapeutics Corp - Eligible to Raise up to $50 Mln Through Second Closing of Private Placement

THOMSON REUTERS
·
Jul 27

Camp4 Therapeutics Secures Australian Regulatory Clearance to Initiate First-in-Human Clinical Trial of Cmp-002 in Patients with Syngap1-Related Disorder

THOMSON REUTERS
·
Jul 27

Camp4 Therapeutics Announces Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)

THOMSON REUTERS
·
Jul 18

Positive Report for CAMP4 Therapeutics Corporation (CAMP) from J.P. Morgan

TIPRANKS
·
Jun 23

Camp4 Therapeutics grants 39,000 inducement stock options at $3.96 per share

Reuters
·
Jun 20

Camp4 Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

THOMSON REUTERS
·
Jun 20

Sector Update: Healthcare

MT Newswires Live
·
Jun 17

Discovr Radio to Embed Across All Four Days of CAMP Toronto in First Major Activation with Beatcave

GlobeNewswire
·
Jun 16

Camp4 Therapeutics upgraded to Overweight from Neutral at JPMorgan

TIPRANKS
·
Jun 16

U.S. RESEARCH ROUNDUP-CAMP4 Therapeutics, Rockwell Automation, Zions Bancorporation

Reuters
·
Jun 16

CAMP4 Shareholders Approve Equity Plan Changes and Inducement Plan

TIPRANKS
·
Jun 13

Camp4 Therapeutics shareholders approve amendment to 2024 equity incentive plan at annual meeting

Reuters
·
Jun 13

CAMP4 Therapeutics Initiated at Buy by Chardan Capital

Dow Jones
·
Jun 10